课题基金 / 基金详情

Nonmuscle Myosin II-C and its Isoform

Nonmuscle Myosin II-C and its Isoform
非肌肉肌球蛋白 II-C 及其异构体
批准号:
7321612
负责人:
ROBERT ADELSTEIN
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:

项目摘要

项目成果

ROBERT ADELSTEIN的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Nonmuscle myosin IIs play an important role during cytokinesis, cell migration and in establishing cell polarity. Three isoforms of nonmuscle myosin heavy chain II (NMHC) have been identified in vertebrates, NMHC II-A, II-B and II-C. For NMHC II-C, an alternative exon encoding 8 amino acids is incorporated into loop1 (NMHC II-C1) and another alternative exon encoding 41 amino acids is introduced into loop2 (NMHC II-C2) at homologous locations to the NMHC II-B inserts in the NMHC. Whereas the tissue distribution of NMHC II-C2 is similar to that of II-B1 and II-B2 is being confined to neuronal tissue, NMHC II-C1 is expressed in a variety of tissues, such as liver, kidney, testes, brain and lung. We recently reported that the expression of NMHC II-C1 isoform is markedly increased in some tumor cell lines and that inhibiting expression leads to a delay in cytokinesis, resulting in a decrease in cell proliferation in the A549 human lung tumor cell line. For in vivo study of nonmuscle myosin II-C1 function, we generated hypomorphic knockout mice using homologous recombination. These mice expressed decreased amounts of myosin II-C, all of which lacked the C1-insert. Some of these mice show evidence for a cardiomyopathy as determined by echocardiography and histopathologic analysis. Of note is that expression of NMHC II-C1 in the heart is restricted to the embryonic stage.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
EXPRESSION OF NONMUSCLE MYOSIN ISOFORMS IN EUKARYOTIC CELLS
NULL MUTATIONS OF VERTEBRATE NONMUSCLE MYOSIN HEAVY CHAINS
INTERACTION OF NONMUSCLE MYOSIN II WITH PLASMA MEMBRANES
EXPRESSION OF NONMUSCLE MYOSIN ISOFORMS IN EUKARYOTIC CELLS
国内基金
海外基金
探索肌球蛋白(myosin)成员在马铃薯纺锤形块茎类病毒(PSTVd)细胞内运动中的作用
  • 批准号:
  • 项目类别:
    面上项目
  • 资助金额:
    50万元
  • 批准年份:
    2024
  • 负责人:
    吴健
  • 依托单位:
抗磷脂综合征新型致病性抗体-抗Myosin5A抗体临床价值的多中心验证研究
肌球蛋白Myosin VI调节自噬影响ER阳性乳腺癌进展和他莫昔芬治疗敏感性的机制研究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    15.0万元
  • 批准年份:
    2024
  • 负责人:
    周珏宇
  • 依托单位:
Myosin19乳酰化致线粒体内嵴结构重排在脓毒症心脏功能障碍中的作用机制